TRDA

Conviction 33HealthcareScan · Mon, Aug 10, 2026

TRDA$6.94+1.02%

ResistanceSupportVol 14Insider buyInsider sell

Vol MA14 495.18K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Entrada Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.entradatx.com ↗

Price6.94

Change+1.02%

Gap+1.16%

Rel volume0.95×

Avg volume472.55K

Avg $ vol3.13M

SMA 206.64

SMA 506.84

SMA 2009.67

Price vs 50+1.45%

Price vs 200-28.20%

MA stackmixed

50/200 cross—

Supertrenddown · 7.34

RSI (14)52

MACD hist0.09

MACD crossbull · 7d

Stoch %K / %D54 / 52

ADX (14)21

+DI / −DI24 / 14

RSI divergence—

MACD divergence—

ATR %+7.67%

ADR %7.69%

52w high16.03

52w low5.02

From 52w high-56.71%

Above 52w low+38.25%

New 52w highNo

SqueezeOff

Bollinger width26.37%

%B0.67

Donchian pos54.22%

Donchian high7.97

Donchian low5.72

AVWAP (52w high)6.93

vs AVWAP high+0.16%

AVWAP (52w low)8.22

vs AVWAP low-15.53%

OBV trendFlat

Chaikin MF (20)-0.08

Today vs 20d0.95×

Avg vol (14d)495.18K

Avg vol (20d)472.55K

Avg $ vol (20d)3.13M

Market cap270.22M

RS 3m (vs SPY)-5.41%

RS 6m (vs SPY)-45.89%

RS line new highNo

Trend template4/8

Technical rank27.9

1 week-4.41%

1 month+0.29%

3 months+1.46%

6 months-34.53%

1 year+30.94%

YTD-30.95%

P/E-1.88

P/B1.16

P/S10.63

P/FCF-2.09

EPS-3.47

Div yield—

ROE-61.59%

ROA-48.10%

Debt/Eq—

Current10.89

EV/EBITDA—

Gross margin—

Net margin-565.48%

Rev growth-87.94%

EPS growth-319.04%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value170.94M

Revenue898K

Net income-42.76M

Gross profit—

Free cash flow-129.55M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out38.82M

Employees152

ListedFri, Oct 29, 2021

Free float23.95M

Float %62.7%

Short interest2.23M

Days to cover6.3d

Short volume23.3%

Squeeze score44 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction33 / 100

Pattern quality—

Tech rank27.9 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance8.04

Support6.09

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in TRDA

All disclosures →

No recent disclosed trades by Congress in TRDA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in TRDA · 2 buys · 3 sells

Insider	Side	Shares	Value	Traded	Filed
Zeiher Bernhardt G Director · Common Stock · 2026-05-20	Buy	5K	$29K	2026-05-20	2026-05-21
Dowden Nathan J President & COO · Common Stock · 2026-05-04	Exercise	15K	$26K	2026-05-04	2026-05-04
Sethuraman Natarajan President, Research & Develop. · Common Stock · 2026-05-04	Sell	25.91K	$399K	2026-05-04	2026-05-04
Dowden Nathan J President & COO · Common Stock · 2026-05-04	Sell	15K	$230K	2026-05-04	2026-05-04
Dowden Nathan J President & COO · Stock Option (Right to Buy) · 2026-05-04	Exercise	15K	$0	2026-05-04	2026-05-04

SEC filings

EDGAR filings in TRDA · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.